NECTIN4 and cancer: Studies have shown that PVRL4 is abnormally overexpressed in a variety of human cancers, including urothelial cancer, bladder cancer, gastric cancer, thyroid cancer, breast cancer, esophageal cancer, and ovarian cancer [24–27].